Inari Medical Inc (NARI)

79.30 -0.15 (-0.19%) USD  |  NASDAQ  |  Jan 08, 16:00
79.32 +0.02 (+0.03%) After-Hours: 20:00
More

Inari Medical SG&A Expense (Quarterly): 108.27M for Sept. 30, 2024

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for NARI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense Definition

View SG&A Expense Definition
Start Trial

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Nevro Corp 68.47M
Inspire Medical Systems Inc 130.39M
TransMedics Group Inc 42.66M
Electromed Inc 9.387M
Myomo Inc 6.654M